1st approved Symbicort generic, Breyna, now available in US
2023年8月7日 · The inhaled medication — the first Symbicort generic to be approved by the U.S. Food and Drug Administration — will become immediately available to eligible patients.. Like …
A form of vitamin B3 lowers COPD lung inflammation: Study
2024年11月25日 · Assessing inflammation with vitamin B supplement. The University of Copenhagen launched a single-center trial (NCT04990869) at the Respiratory Research Unit …
Low-dose Morphine Improves Health in COPD Patients With …
2020年9月3日 · So, researchers based at the Maastricht University in the Netherlands designed the Morphine for Treatment of Dyspnea in Patients With COPD (MORDYC) Phase 4 study …
Dupixent approved in US for adults with poorly controlled COPD
2024年9月30日 · In the U.S., the expansion of Dupixent’s label to include COPD brings the number of approved indications up to six, adding to its use as a treatment for atopic dermatitis, …
Ohtuvayre effective across key patient subgroups: ENHANCE trials
2024年10月14日 · In an oral presentation titled “Ensifentrine Improved Lung Function, Symptoms, and Quality of Life Regardless of COPD Severity,” Jessica M. Bon, MD, of Wake Forest …
In COPD with type 2 inflammation, exacerbations lowered with...
2024年9月16日 · That’s according to top-line data from a Phase 3 clinical trial called MATINEE (NCT04133909) announced by GSK in a company press release.The study tested …
Cold and windy weather brings about challenges with COPD
2025年1月14日 · In addition, extreme weather events can contribute to the worsening of COPD symptoms or exacerbations and lead to hospitalizations, as COPD News Today reported in …
Dupixent (dupilumab) for COPD | COPD News Today
2024年11月18日 · How does Dupixent work? COPD is a chronic, progressive lung disease, characterized by progressive airway inflammation and narrowing, that leads to symptoms such …
Ensifentrine, now Ohtuvayre, wins FDA approval for COPD
2024年6月27日 · Verona did not specify the list price for the newly approved therapy. According to an analysis from the Institute for Clinical Economic Review (ICER), Ohtuvayre would meet …
KT-621, potential medication for COPD, cleared for human trials
2024年10月21日 · KT-621 is designed to target STAT6, a protein involved in type 2 inflammation, which is marked by high blood counts of eosinophils, a type of immune cell, and is thought to …